Cornerstone Advisors (Washington)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-140
| Closed | -$4K | – | 1175 |
|
|
2019
Q2 | $4K | Hold |
140
| – | – | ﹤0.01% | 972 |
|
|
2019
Q1 | $5K | Sell |
140
-21
| -13% | -$750 | ﹤0.01% | 834 |
|
|
2018
Q4 | $5K | Hold |
161
| – | – | ﹤0.01% | 774 |
|
|
2018
Q3 | $7K | Hold |
161
| – | – | ﹤0.01% | 714 |
|
|
2018
Q2 | $6K | Hold |
161
| – | – | ﹤0.01% | 701 |
|
|
2018
Q1 | $5K | Buy |
161
+21
| +15% | +$652 | ﹤0.01% | 706 |
|
|
2017
Q4 | $5K | Hold |
140
| – | – | ﹤0.01% | 704 |
|
|
2017
Q3 | $5K | Hold |
140
| – | – | ﹤0.01% | 698 |
|
|
2017
Q2 | $4K | Hold |
140
| – | – | ﹤0.01% | 722 |
|
|
2017
Q1 | $3K | Hold |
140
| – | – | ﹤0.01% | 753 |
|
|
2016
Q4 | $2K | Hold |
140
| – | – | ﹤0.01% | 819 |
|
|
2016
Q3 | $3K | Sell |
140
-140
| -50% | -$3K | ﹤0.01% | 746 |
|
|
2016
Q2 | $9K | Hold |
280
| – | – | 0.01% | 440 |
|
|
2016
Q1 | $10K | Hold |
280
| – | – | 0.01% | 422 |
|
|
2015
Q4 | $12K | Hold |
280
| – | – | 0.01% | 410 |
|
|
2015
Q3 | $10K | Buy |
+280
| New | +$10K | 0.01% | 450 |
|